Yestar Healthcare Holdings Co Ltd
HHKEX:23930.07
HKD
+0.00
(-5.80%)
ISIN
KYG9843W1125
CUSIP
G9843W112
Return %
Stock
S&P 500
1Y
-53.24
14.39
3Y
-64.48
81.42
5Y
-93.75
68.62
Capital Structure
CNY
•
in mil. unless spec.Working Capital
CNY
•
in mil. unless spec.Growth Rates
CNY
•
in mil. unless spec.Semi-annual Revenue
CNY
•
in mil. unless spec.Semi-annual Earnings Per Share
CNY
•
in mil. unless spec.Semi-annual Dividends Per Share
CNY
•
in mil. unless spec.Company Description
- CEO
- Chun Lai Wang
- Full Time Employees
- 448
- Sector
- Distribution services
- Industry
- Medical distributors
- Address
- Green Land Building Pudong SH China 201199
- IPO Date
- Oct 11, 2013
- Website
- yestarcorp.com
- Similar Companies
- Business
- Yestar Healthcare Holdings Company Limited operates as a leading medical consumables and equipment company primarily in the People's Republic of China. Its core products include high-margin medical imaging films for X-Ray, MRI, and CT-scan under contract manufacturing agreements with Fujifilm, as well as dental films and medical dry film products marketed under its own brand "Yes! Star." The company focuses extensively on in vitro diagnostic (IVD) products distribution, building a solid sales network across multiple provinces and tier-one cities in China. Yestar’s portfolio also encompasses provision of value-added services in oncology, early cancer screening, and genomic profiling, supported by partnerships to integrate advanced diagnostic technologies. Recent major developments include a strategic joint venture formed in Singapore with New Genetron Holding Limited aimed at establishing clinical molecular diagnostics laboratories in Indonesia to expand precision oncology services across Southeast Asia. This initiative enhances the company’s footprint beyond China and brings advanced genomic profiling-based cancer screening to new regional markets. Additionally, Yestar completed significant equity acquisitions, including an increase in holdings within subsidiaries such as Shengshiyuan and the Anbaida Group Companies, marking a consolidation of operations. The company continues to innovate by expanding its product lineup, including the launch of new disinfectant and mask products amid ongoing health concerns, and nurturing a downstream expansion into independent clinical laboratories. Founded in 1997 and headquartered in China, Yestar Healthcare operates primarily in the healthcare equipment and supplies sector. It services hospitals, clinical laboratories, and healthcare institutions across mainland China and is actively broadening its geographic and product-market boundaries into Southeast Asia. The company balances distribution, manufacturing, and healthcare service segments supported by a rigorous management system and targeted account penetration strategies to drive growth in both first-tier and secondary markets. Its offerings span medical imaging consumables, IVD products, oncology diagnostics, and healthcare supplies, anchored by strategic collaborations and vertical integration to strengthen its position in the high-value healthcare consumables market.